Reason for request
Inscription
Clinical Benefit
Substantial |
Le service médical rendu par PROPOFOL PANPHARMA 10 mg/mL et 20 mg/mL en émulsion injectable (IV) est important dans les indications de l’AMM.
|
Clinical Added Value
no clinical added value |
Ces deux spécialités, génériques de DIPRIVAN, n’apportent pas d’amélioration du service médical rendu (ASMR V, inexistante).
|
eNq9mF1v2jAUhu/5FVHukxBaIEyBamPthtRqjBZt2g0yyUkxC3bqDz726+cQutHJUVtT7zJ28p4Tn9ePjxxfbFe5swbGMSV9N/SbrgMkoSkm9313enflRe7FoBEv0Rodvdb1m37Ycp0kR5z33XLWnwMi3P9+c/0R1PfA3EHDiel8CYl48p4UOPc/I764QUX5jhOvKU6dFYgFTftuIcV+1Im5YCqLwYayn7xACcTBYeR4djk7Px6Pg1LsBaqSA7tG5F4rCsRIM5GMARFDJOCesp1WOktmrajbaTYjoxCYT4BTyRIYI7EYM7rGKaT6SCjnYBQk26S3wNY5iDKIVjxYJituJI6WaDuBh5E+6fdqdii2wmt6YbcdNTvds1bY7fWMQrGjpdKbR/1EkMzCTrsVnfcCIEHBaEEzmnsFIsUCsRXyHocM6zWmTKDcUqUwHz71nKU4DB6edUSKeZGjnb/khelSIYbUNDBFBns/Uv7BHVOsytWa/aNPZJ4Hr8x6eiCJpYxLUA2pJKIGKFcT04UYUiJgW19RMwaK7cGLGPjbyf6iRM//sZznODHFnAKRBC6mk1E95WwD4gPiMGX2CPENk5Ru+NuT57jSlrIv9vDUihYsDWetXtQJ223jjfVD2armJLqUqqwQKCZhfgpqRiSjp0JGOVUv9ehTqxbdt0o0QTnUNEueIYOUNx97O2vut7ezqgmt6KfLO1PLfJXAdrf7R600Tvt/im0GaBvUVwatTfz1dq92/Qva6PPorGVmaaaHykKIgr8Lgs1m4y8Q9zhSi+Vn7L8cBEfnsb3G3sqhXzVBFUwtpT6vTsnXVc10Ez7XFpza6h6+P7TU2hiCSTihFhWvrVF1dPn2oP7b51pLe/wELPbC7HtSJDAltvoiOdcqnnY0qLqSK6YA8SXLcM19S60v46C66xk04qC85xk0fgOfWwhB
guErkCCS89SzyE4X